Our Pipeline
Pipeline
Selective Immunoproteasome Inhibition
Selective Immunoproteasome Inhibition
Title | DiscoveryDisc | Phase 1Ph1 | Phase 2Ph2 | Phase 3Ph3 |
|---|---|---|---|---|
Zetomipzomib (KZR-616) | ||||
| Lupus Nephritis (LN) | Zetomipzomib (KZR-616)Lupus Nephritis (LN) | |||
| Autoimmune Hepatitis (AIH) | Autoimmune Hepatitis (AIH) | |||
| Dermatomyositis (DM) Polymyositis (PM) | Dermatomyositis (DM) Polymyositis (PM) | |||
Protein Secretion Inhibition
Protein Secretion Inhibition
Title | DiscoveryDisc | Phase 1Ph1 | Phase 2Ph2 | Phase 3Ph3 |
|---|---|---|---|---|
KZR-261 | ||||
| Advanced/Metastatic Solid Tumor | KZR-261Advanced/Metastatic Solid Tumor | |||
Oral Anti-PD-1 | ||||
| Single Target Oncology | Oral Anti-PD-1Single Target Oncology | |||
KZR-TBD | ||||
| Multi Target Oncology | KZR-TBDMulti Target Oncology | |||